CN113679818A - Composition for treating gout and rheumatoid osteoarthritis and preparation method thereof - Google Patents
Composition for treating gout and rheumatoid osteoarthritis and preparation method thereof Download PDFInfo
- Publication number
- CN113679818A CN113679818A CN202111194645.XA CN202111194645A CN113679818A CN 113679818 A CN113679818 A CN 113679818A CN 202111194645 A CN202111194645 A CN 202111194645A CN 113679818 A CN113679818 A CN 113679818A
- Authority
- CN
- China
- Prior art keywords
- parts
- root
- radix
- composition
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 57
- 201000005569 Gout Diseases 0.000 title claims abstract description 39
- 238000002360 preparation method Methods 0.000 title claims abstract description 34
- 201000008482 osteoarthritis Diseases 0.000 title claims abstract description 29
- 240000006927 Foeniculum vulgare Species 0.000 claims abstract description 24
- 235000004204 Foeniculum vulgare Nutrition 0.000 claims abstract description 24
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 24
- 241000301400 Trogopterus Species 0.000 claims abstract description 24
- 210000003608 fece Anatomy 0.000 claims abstract description 24
- 240000007311 Commiphora myrrha Species 0.000 claims abstract description 23
- 235000006965 Commiphora myrrha Nutrition 0.000 claims abstract description 23
- 235000017443 Hedysarum boreale Nutrition 0.000 claims abstract description 23
- 235000007858 Hedysarum occidentale Nutrition 0.000 claims abstract description 23
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 claims abstract description 23
- 241000132012 Atractylodes Species 0.000 claims abstract description 22
- 235000007866 Chamaemelum nobile Nutrition 0.000 claims abstract description 22
- 235000007232 Matricaria chamomilla Nutrition 0.000 claims abstract description 22
- 235000007265 Myrrhis odorata Nutrition 0.000 claims abstract description 22
- 244000197580 Poria cocos Species 0.000 claims abstract description 22
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 22
- 244000037364 Cinnamomum aromaticum Species 0.000 claims abstract description 21
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims abstract description 21
- 241000047795 Hydrangea ampla Species 0.000 claims abstract description 21
- 235000006886 Zingiber officinale Nutrition 0.000 claims abstract description 21
- 235000006533 astragalus Nutrition 0.000 claims abstract description 21
- 235000008397 ginger Nutrition 0.000 claims abstract description 21
- 241000427159 Achyranthes Species 0.000 claims abstract description 19
- 210000000582 semen Anatomy 0.000 claims abstract description 18
- 241000112528 Ligusticum striatum Species 0.000 claims abstract description 13
- 244000140786 Brassica hirta Species 0.000 claims abstract description 12
- 235000011371 Brassica hirta Nutrition 0.000 claims abstract description 12
- 241001061264 Astragalus Species 0.000 claims abstract description 11
- 235000006463 Brassica alba Nutrition 0.000 claims abstract description 11
- 210000004233 talus Anatomy 0.000 claims abstract description 11
- 241000628997 Flos Species 0.000 claims abstract description 9
- 241001057584 Myrrha Species 0.000 claims abstract description 8
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims abstract description 7
- 241000220261 Sinapis Species 0.000 claims abstract description 7
- 244000273928 Zingiber officinale Species 0.000 claims abstract description 5
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract 5
- 244000042664 Matricaria chamomilla Species 0.000 claims abstract 5
- 239000006187 pill Substances 0.000 claims description 39
- 241000227129 Aconitum Species 0.000 claims description 24
- 238000002156 mixing Methods 0.000 claims description 21
- 241001180876 Saposhnikovia Species 0.000 claims description 19
- 239000007788 liquid Substances 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- 241000045403 Astragalus propinquus Species 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 10
- 238000002791 soaking Methods 0.000 claims description 10
- 235000017803 cinnamon Nutrition 0.000 claims description 9
- 235000012907 honey Nutrition 0.000 claims description 9
- 239000009636 Huang Qi Substances 0.000 claims description 7
- 238000001914 filtration Methods 0.000 claims description 7
- 239000002994 raw material Substances 0.000 claims description 7
- 238000007873 sieving Methods 0.000 claims description 7
- 241000212322 Levisticum officinale Species 0.000 claims description 6
- 239000001645 levisticum officinale Substances 0.000 claims description 6
- 239000002904 solvent Substances 0.000 claims description 6
- 235000008216 herbs Nutrition 0.000 claims description 4
- 244000236521 Bupleurum rotundifolium Species 0.000 claims description 2
- 235000015221 Bupleurum rotundifolium Nutrition 0.000 claims description 2
- 239000012669 liquid formulation Substances 0.000 claims description 2
- 238000010298 pulverizing process Methods 0.000 claims description 2
- 244000223760 Cinnamomum zeylanicum Species 0.000 claims 3
- 230000000694 effects Effects 0.000 abstract description 40
- 210000000952 spleen Anatomy 0.000 abstract description 21
- 239000008280 blood Substances 0.000 abstract description 19
- 210000004369 blood Anatomy 0.000 abstract description 19
- 230000001737 promoting effect Effects 0.000 abstract description 18
- 229940107666 astragalus root Drugs 0.000 abstract description 12
- 230000017531 blood circulation Effects 0.000 abstract description 9
- 208000004880 Polyuria Diseases 0.000 abstract description 7
- 230000035619 diuresis Effects 0.000 abstract description 7
- 230000001717 pathogenic effect Effects 0.000 abstract description 7
- 241000173529 Aconitum napellus Species 0.000 abstract description 6
- 206010030113 Oedema Diseases 0.000 abstract description 6
- 229940023019 aconite Drugs 0.000 abstract description 6
- 230000001939 inductive effect Effects 0.000 abstract description 6
- 241000229179 Ledebouriella Species 0.000 abstract description 5
- 230000003213 activating effect Effects 0.000 abstract description 5
- 241000202726 Bupleurum Species 0.000 abstract description 4
- 238000005469 granulation Methods 0.000 abstract description 4
- 230000003179 granulation Effects 0.000 abstract description 4
- 230000027939 micturition Effects 0.000 abstract description 3
- 230000007123 defense Effects 0.000 abstract description 2
- 239000002552 dosage form Substances 0.000 abstract description 2
- 238000001035 drying Methods 0.000 abstract description 2
- 239000003053 toxin Substances 0.000 abstract description 2
- 231100000765 toxin Toxicity 0.000 abstract description 2
- 229940126680 traditional chinese medicines Drugs 0.000 abstract description 2
- 208000002193 Pain Diseases 0.000 description 35
- 230000036407 pain Effects 0.000 description 35
- 239000003814 drug Substances 0.000 description 27
- 241000244355 Ligusticum Species 0.000 description 18
- 240000003538 Chamaemelum nobile Species 0.000 description 17
- 241000234314 Zingiber Species 0.000 description 16
- 210000003734 kidney Anatomy 0.000 description 15
- 210000004185 liver Anatomy 0.000 description 15
- 239000000126 substance Substances 0.000 description 15
- 239000000341 volatile oil Substances 0.000 description 13
- 201000010099 disease Diseases 0.000 description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 11
- 235000009508 confectionery Nutrition 0.000 description 10
- 230000007812 deficiency Effects 0.000 description 10
- 210000002784 stomach Anatomy 0.000 description 10
- 238000010792 warming Methods 0.000 description 10
- 230000009471 action Effects 0.000 description 9
- 210000002216 heart Anatomy 0.000 description 9
- 210000004072 lung Anatomy 0.000 description 9
- 208000011580 syndromic disease Diseases 0.000 description 9
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 8
- 239000003921 oil Substances 0.000 description 8
- 241000723347 Cinnamomum Species 0.000 description 7
- 206010012735 Diarrhoea Diseases 0.000 description 7
- 206010042674 Swelling Diseases 0.000 description 7
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 7
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 7
- 229920001282 polysaccharide Polymers 0.000 description 7
- 239000005017 polysaccharide Substances 0.000 description 7
- 230000008961 swelling Effects 0.000 description 7
- 229940116269 uric acid Drugs 0.000 description 7
- 208000004998 Abdominal Pain Diseases 0.000 description 6
- 208000005171 Dysmenorrhea Diseases 0.000 description 6
- 206010013935 Dysmenorrhoea Diseases 0.000 description 6
- 235000001188 Peltandra virginica Nutrition 0.000 description 6
- 235000013399 edible fruits Nutrition 0.000 description 6
- 150000004676 glycans Chemical class 0.000 description 6
- 230000001965 increasing effect Effects 0.000 description 6
- 230000000144 pharmacologic effect Effects 0.000 description 6
- 235000019633 pungent taste Nutrition 0.000 description 6
- 208000006820 Arthralgia Diseases 0.000 description 5
- 239000000796 flavoring agent Substances 0.000 description 5
- 235000019634 flavors Nutrition 0.000 description 5
- 238000005728 strengthening Methods 0.000 description 5
- 235000019640 taste Nutrition 0.000 description 5
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 4
- 239000005770 Eugenol Substances 0.000 description 4
- 206010016807 Fluid retention Diseases 0.000 description 4
- -1 Glycyrrhiza polysaccharide Chemical class 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 4
- 210000000988 bone and bone Anatomy 0.000 description 4
- 210000001185 bone marrow Anatomy 0.000 description 4
- ZZAJQOPSWWVMBI-UHFFFAOYSA-N calycosin Chemical compound C1=C(O)C(OC)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZZAJQOPSWWVMBI-UHFFFAOYSA-N 0.000 description 4
- 229960002217 eugenol Drugs 0.000 description 4
- 210000003414 extremity Anatomy 0.000 description 4
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 4
- HKQYGTCOTHHOMP-UHFFFAOYSA-N formononetin Chemical compound C1=CC(OC)=CC=C1C1=COC2=CC(O)=CC=C2C1=O HKQYGTCOTHHOMP-UHFFFAOYSA-N 0.000 description 4
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 4
- 210000001503 joint Anatomy 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 241001671653 Aconitum carmichaelii Species 0.000 description 3
- 201000000736 Amenorrhea Diseases 0.000 description 3
- 206010001928 Amenorrhoea Diseases 0.000 description 3
- 241000208173 Apiaceae Species 0.000 description 3
- LAWPHHZXTUPSDG-UHFFFAOYSA-N Astragaloside I Natural products CC(=O)OC1C(O)COC(OC2CCC34CC35CCC6(C)C(C)(CCC6(O)C7(C)CCC(O7)C(C)(C)O)C5CC(OC8OC(CO)C(O)C(O)C8O)C4C2(C)C)C1OC(=O)C LAWPHHZXTUPSDG-UHFFFAOYSA-N 0.000 description 3
- KXHCYYSIAXMSPA-UHFFFAOYSA-N Astragaloside-I Chemical compound CC(=O)OC1C(OC(=O)C)C(O)COC1OC1C(C)(C)C2C(OC3C(C(O)C(O)C(CO)O3)O)CC3C4(C)CC(O)C(C5(C)OC(CC5)C(C)(C)O)C4(C)CCC43CC42CC1 KXHCYYSIAXMSPA-UHFFFAOYSA-N 0.000 description 3
- 244000080208 Canella winterana Species 0.000 description 3
- 235000008499 Canella winterana Nutrition 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 208000005392 Spasm Diseases 0.000 description 3
- 206010047700 Vomiting Diseases 0.000 description 3
- 208000031975 Yang Deficiency Diseases 0.000 description 3
- 230000003187 abdominal effect Effects 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 3
- 229930013930 alkaloid Natural products 0.000 description 3
- 231100000540 amenorrhea Toxicity 0.000 description 3
- 229940024606 amino acid Drugs 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000000202 analgesic effect Effects 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 208000006673 asthma Diseases 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 229940076810 beta sitosterol Drugs 0.000 description 3
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 3
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 3
- QXMNTPFFZFYQAI-IMDKZJJXSA-N beta-sitosterol 3-O-beta-D-glucopyranoside Natural products CC[C@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@H](CC[C@]4(C)[C@H]3CC[C@]12C)O[C@@H]5C[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)C(C)C QXMNTPFFZFYQAI-IMDKZJJXSA-N 0.000 description 3
- 229940017545 cinnamon bark Drugs 0.000 description 3
- NPJICTMALKLTFW-OFUAXYCQSA-N daucosterol Chemical compound O([C@@H]1CC2=CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CC[C@@H](CC)C(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O NPJICTMALKLTFW-OFUAXYCQSA-N 0.000 description 3
- QDFKFNAHVGPRBL-UHFFFAOYSA-N daucosterol Natural products CCC(CCC(C)C1CCC2C1CCC3C2(C)CC=C4CC(CCC34C)OC5OC(CO)C(O)C(O)C5O)C(C)C QDFKFNAHVGPRBL-UHFFFAOYSA-N 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 208000016253 exhaustion Diseases 0.000 description 3
- 239000010685 fatty oil Substances 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 210000000629 knee joint Anatomy 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 3
- 229950005143 sitosterol Drugs 0.000 description 3
- 235000013599 spices Nutrition 0.000 description 3
- 210000004243 sweat Anatomy 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- RUVINXPYWBROJD-ONEGZZNKSA-N trans-anethole Chemical compound COC1=CC=C(\C=C\C)C=C1 RUVINXPYWBROJD-ONEGZZNKSA-N 0.000 description 3
- 230000008736 traumatic injury Effects 0.000 description 3
- 239000001169 1-methyl-4-propan-2-ylcyclohexa-1,4-diene Substances 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- HCXVJBMSMIARIN-ZETWWWAOSA-N 24alpha-Ethyl-koprostanol Natural products CC[C@H](C=C[C@H](C)[C@H]1CC[C@@H]2[C@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C)C(C)C HCXVJBMSMIARIN-ZETWWWAOSA-N 0.000 description 2
- 240000000031 Achyranthes bidentata Species 0.000 description 2
- 241000219317 Amaranthaceae Species 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 2
- 241000208838 Asteraceae Species 0.000 description 2
- LVBLYMQWWGLBRE-UHFFFAOYSA-N Astragaloside-II Chemical compound CC(=O)OC1C(C(COC1OC2CCC34CC35CCC6(C(C(CC6(C5CC(C4C2)OC7C(C(C(C(O7)CO)O)O)O)C)O)C8(CCC(O8)C(C)(C)O)C)C)O)O LVBLYMQWWGLBRE-UHFFFAOYSA-N 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 235000021511 Cinnamomum cassia Nutrition 0.000 description 2
- 244000167125 Cinnamomum japonicum Species 0.000 description 2
- 235000002428 Cinnamomum japonicum Nutrition 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 241000514824 Cyathula officinalis Species 0.000 description 2
- ZFMSMUAANRJZFM-UHFFFAOYSA-N Estragole Chemical compound COC1=CC=C(CC=C)C=C1 ZFMSMUAANRJZFM-UHFFFAOYSA-N 0.000 description 2
- 241000220485 Fabaceae Species 0.000 description 2
- 241000202807 Glycyrrhiza Species 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 206010019909 Hernia Diseases 0.000 description 2
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 description 2
- 206010023232 Joint swelling Diseases 0.000 description 2
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 2
- ZYEMGPIYFIJGTP-UHFFFAOYSA-N O-methyleugenol Chemical compound COC1=CC=C(CC=C)C=C1OC ZYEMGPIYFIJGTP-UHFFFAOYSA-N 0.000 description 2
- 235000021314 Palmitic acid Nutrition 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 241000405414 Rehmannia Species 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- FINHMKGKINIASC-UHFFFAOYSA-N Tetramethylpyrazine Chemical compound CC1=NC(C)=C(C)N=C1C FINHMKGKINIASC-UHFFFAOYSA-N 0.000 description 2
- 241000301399 Trogopterus xanthipes Species 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000003797 alkaloid derivatives Chemical class 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- JZVFJDZBLUFKCA-FXIAWGAOSA-N alpha-Spinasterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)CC[C@H]33)C)C3=CC[C@H]21 JZVFJDZBLUFKCA-FXIAWGAOSA-N 0.000 description 2
- JZVFJDZBLUFKCA-UTQQLQBSSA-N alpha-spinasterol Natural products CC[C@H](C=C[C@H](C)[C@H]1CC[C@H]2C3=CC[C@@H]4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C JZVFJDZBLUFKCA-UTQQLQBSSA-N 0.000 description 2
- 230000003266 anti-allergic effect Effects 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 208000003464 asthenopia Diseases 0.000 description 2
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N benzo-alpha-pyrone Natural products C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 2
- UAHWPYUMFXYFJY-UHFFFAOYSA-N beta-myrcene Chemical compound CC(C)=CCCC(=C)C=C UAHWPYUMFXYFJY-UHFFFAOYSA-N 0.000 description 2
- 235000019658 bitter taste Nutrition 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- CRPUJAZIXJMDBK-UHFFFAOYSA-N camphene Chemical compound C1CC2C(=C)C(C)(C)C1C2 CRPUJAZIXJMDBK-UHFFFAOYSA-N 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 235000001671 coumarin Nutrition 0.000 description 2
- HJCCJZGOBHFQSX-UHFFFAOYSA-N cyclosieversioside B Natural products CC(CCC(O)C(C)(C)OC1OC(CO)C(O)C(O)C1O)C2C(CC3(C)C4CC(O)C5C(C)(C)C(CCC56CC46CCC23C)OC7OCC(O)C(O)C7O)OC8OC(CO)C(O)C(O)C8O HJCCJZGOBHFQSX-UHFFFAOYSA-N 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 235000019152 folic acid Nutrition 0.000 description 2
- 239000011724 folic acid Substances 0.000 description 2
- 229960000304 folic acid Drugs 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- RIKPNWPEMPODJD-UHFFFAOYSA-N formononetin Natural products C1=CC(OC)=CC=C1C1=COC2=CC=CC=C2C1=O RIKPNWPEMPODJD-UHFFFAOYSA-N 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- NLDDIKRKFXEWBK-AWEZNQCLSA-N gingerol Chemical compound CCCCC[C@H](O)CC(=O)CCC1=CC=C(O)C(OC)=C1 NLDDIKRKFXEWBK-AWEZNQCLSA-N 0.000 description 2
- JZLXEKNVCWMYHI-UHFFFAOYSA-N gingerol Natural products CCCCC(O)CC(=O)CCC1=CC=C(O)C(OC)=C1 JZLXEKNVCWMYHI-UHFFFAOYSA-N 0.000 description 2
- 235000002780 gingerol Nutrition 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- VKOBVWXKNCXXDE-UHFFFAOYSA-N icosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCC(O)=O VKOBVWXKNCXXDE-UHFFFAOYSA-N 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 208000010553 multiple abscesses Diseases 0.000 description 2
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 2
- 201000009240 nasopharyngitis Diseases 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- ZRSNZINYAWTAHE-UHFFFAOYSA-N p-methoxybenzaldehyde Chemical compound COC1=CC=C(C=O)C=C1 ZRSNZINYAWTAHE-UHFFFAOYSA-N 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- CNVZJPUDSLNTQU-SEYXRHQNSA-N petroselinic acid Chemical compound CCCCCCCCCCC\C=C/CCCCC(O)=O CNVZJPUDSLNTQU-SEYXRHQNSA-N 0.000 description 2
- 150000007875 phellandrene derivatives Chemical class 0.000 description 2
- 150000002989 phenols Chemical class 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- ZMQAAUBTXCXRIC-UHFFFAOYSA-N safrole Chemical compound C=CCC1=CC=C2OCOC2=C1 ZMQAAUBTXCXRIC-UHFFFAOYSA-N 0.000 description 2
- HUJXHFRXWWGYQH-UHFFFAOYSA-O sinapine Chemical compound COC1=CC(\C=C\C(=O)OCC[N+](C)(C)C)=CC(OC)=C1O HUJXHFRXWWGYQH-UHFFFAOYSA-O 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 210000000115 thoracic cavity Anatomy 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- 150000003648 triterpenes Chemical class 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 210000003932 urinary bladder Anatomy 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- OJYLAHXKWMRDGS-UHFFFAOYSA-N zingerone Chemical compound COC1=CC(CCC(C)=O)=CC=C1O OJYLAHXKWMRDGS-UHFFFAOYSA-N 0.000 description 2
- GRWFGVWFFZKLTI-UHFFFAOYSA-N α-pinene Chemical compound CC1=CCC2C(C)(C)C1C2 GRWFGVWFFZKLTI-UHFFFAOYSA-N 0.000 description 2
- YKFLAYDHMOASIY-UHFFFAOYSA-N γ-terpinene Chemical compound CC(C)C1=CCC(C)=CC1 YKFLAYDHMOASIY-UHFFFAOYSA-N 0.000 description 2
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 description 1
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 1
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 1
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 1
- BAPAICNRGIBFJT-UHFFFAOYSA-O (4-Hydroxybenzoyl)choline Chemical compound C[N+](C)(C)CCOC(=O)C1=CC=C(O)C=C1 BAPAICNRGIBFJT-UHFFFAOYSA-O 0.000 description 1
- ZGDVRBVTNMQMEX-LDHZKLTISA-N (8r,9s,10s,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylhept-6-en-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthrene Chemical compound C1CC2CCCC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@@H](CCCC(C)=C)C)[C@@]1(C)CC2 ZGDVRBVTNMQMEX-LDHZKLTISA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
- KJPRLNWUNMBNBZ-QPJJXVBHSA-N (E)-cinnamaldehyde Chemical compound O=C\C=C\C1=CC=CC=C1 KJPRLNWUNMBNBZ-QPJJXVBHSA-N 0.000 description 1
- IQVQXVFMNOFTMU-FLIBITNWSA-N (Z)-ligustilide Chemical compound C1CC=CC2=C1C(=C/CCC)/OC2=O IQVQXVFMNOFTMU-FLIBITNWSA-N 0.000 description 1
- OXEDXHIBHVMDST-UHFFFAOYSA-N 12Z-octadecenoic acid Natural products CCCCCC=CCCCCCCCCCCC(O)=O OXEDXHIBHVMDST-UHFFFAOYSA-N 0.000 description 1
- GRWFGVWFFZKLTI-IUCAKERBSA-N 1S,5S-(-)-alpha-Pinene Natural products CC1=CC[C@@H]2C(C)(C)[C@H]1C2 GRWFGVWFFZKLTI-IUCAKERBSA-N 0.000 description 1
- NKDFYOWSKOHCCO-YPVLXUMRSA-N 20-hydroxyecdysone Chemical compound C1[C@@H](O)[C@@H](O)C[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@@](C)(O)[C@H](O)CCC(C)(O)C)CC[C@]33O)C)C3=CC(=O)[C@@H]21 NKDFYOWSKOHCCO-YPVLXUMRSA-N 0.000 description 1
- HXWZQRICWSADMH-SEHXZECUSA-N 20-hydroxyecdysone Natural products CC(C)(C)CC[C@@H](O)[C@@](C)(O)[C@H]1CC[C@@]2(O)C3=CC(=O)[C@@H]4C[C@@H](O)[C@@H](O)C[C@]4(C)[C@H]3CC[C@]12C HXWZQRICWSADMH-SEHXZECUSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- AMKMYXVFAOJGGQ-UHFFFAOYSA-N 4-(methylaminomethyl)phenol Chemical compound CNCC1=CC=C(O)C=C1 AMKMYXVFAOJGGQ-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 206010000242 Abortion threatened Diseases 0.000 description 1
- 241000701413 Aconitum kusnezoffii Species 0.000 description 1
- TWCMVXMQHSVIOJ-UHFFFAOYSA-N Aglycone of yadanzioside D Natural products COC(=O)C12OCC34C(CC5C(=CC(O)C(O)C5(C)C3C(O)C1O)C)OC(=O)C(OC(=O)C)C24 TWCMVXMQHSVIOJ-UHFFFAOYSA-N 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010059313 Anogenital warts Diseases 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- JLKGXASMCRAVAK-UHFFFAOYSA-N Astragaloside-II Natural products CC(=O)OC1C(O)C(O)COC1OC2CCC34CC35CCC6(C)C(C)(CCC6(O)C7(C)CCC(O7)C(C)(C)O)C5CC(OC8OC(CO)C(O)C(O)C8O)C4C2(C)C JLKGXASMCRAVAK-UHFFFAOYSA-N 0.000 description 1
- PLMKQQMDOMTZGG-UHFFFAOYSA-N Astrantiagenin E-methylester Natural products CC12CCC(O)C(C)(CO)C1CCC1(C)C2CC=C2C3CC(C)(C)CCC3(C(=O)OC)CCC21C PLMKQQMDOMTZGG-UHFFFAOYSA-N 0.000 description 1
- 241000092665 Atractylodes macrocephala Species 0.000 description 1
- TYPSVDGIQAOBAD-DZGCQCFKSA-N Atractylone Chemical compound C([C@]1(C)C2)CCC(=C)[C@@H]1CC1=C2OC=C1C TYPSVDGIQAOBAD-DZGCQCFKSA-N 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 206010049765 Bradyarrhythmia Diseases 0.000 description 1
- 241000219193 Brassicaceae Species 0.000 description 1
- 241000510654 Bupleurum chinense Species 0.000 description 1
- 241000213015 Bupleurum scorzonerifolium Species 0.000 description 1
- 241000208229 Burseraceae Species 0.000 description 1
- 241000282461 Canis lupus Species 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 241001507936 Chaenomeles Species 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
- 241000159174 Commiphora Species 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 241000241550 Cyathula Species 0.000 description 1
- DJHCVWLJAINILQ-UHFFFAOYSA-N Cyclosieversioside D Natural products CC(=O)OC1C(O)C(O)COC1OC2CCC34CC35CCC6(C)C(C(O)CC6(C)C5CC(OC7OC(CO)C(O)C(O)C7O)C4C2(C)C)C8(C)CC(CO8)C(C)(C)O DJHCVWLJAINILQ-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- DCEFCUHVANGEOE-UHFFFAOYSA-N Ecdysterone Natural products CC(CC(C)(C)O)C(O)C(C)(O)C1CCC2(O)C3=CC(=O)C4CC(O)C(O)CC4(C)C3CCC12C DCEFCUHVANGEOE-UHFFFAOYSA-N 0.000 description 1
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 1
- 206010016717 Fistula Diseases 0.000 description 1
- 241000212314 Foeniculum Species 0.000 description 1
- 208000036119 Frailty Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 206010017711 Gangrene Diseases 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 241000558306 Gynocardia odorata Species 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 241000382951 Hansenia forbesii Species 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- FSBIGDSBMBYOPN-VKHMYHEASA-N L-canavanine Chemical compound OC(=O)[C@@H](N)CCONC(N)=N FSBIGDSBMBYOPN-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- 241000218195 Lauraceae Species 0.000 description 1
- 241000244365 Ligusticum sinense Species 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010052904 Musculoskeletal stiffness Diseases 0.000 description 1
- FSBIGDSBMBYOPN-UHFFFAOYSA-N O-guanidino-DL-homoserine Natural products OC(=O)C(N)CCON=C(N)N FSBIGDSBMBYOPN-UHFFFAOYSA-N 0.000 description 1
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- CNVZJPUDSLNTQU-UHFFFAOYSA-N Petroselaidic acid Natural products CCCCCCCCCCCC=CCCCCC(O)=O CNVZJPUDSLNTQU-UHFFFAOYSA-N 0.000 description 1
- 241000222341 Polyporaceae Species 0.000 description 1
- PXRCIOIWVGAZEP-UHFFFAOYSA-N Primaeres Camphenhydrat Natural products C1CC2C(O)(C)C(C)(C)C1C2 PXRCIOIWVGAZEP-UHFFFAOYSA-N 0.000 description 1
- 208000012287 Prolapse Diseases 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- LZEPVVDVBJUKSG-UHFFFAOYSA-N Pterocarpan Natural products C1=CC=C2C3COC4=CC=CC=C4C3OC2=C1 LZEPVVDVBJUKSG-UHFFFAOYSA-N 0.000 description 1
- 206010037544 Purging Diseases 0.000 description 1
- 241000218201 Ranunculaceae Species 0.000 description 1
- 206010057071 Rectal tenesmus Diseases 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 206010061481 Renal injury Diseases 0.000 description 1
- 241001180873 Saposhnikovia divaricata Species 0.000 description 1
- 241000220151 Saxifragaceae Species 0.000 description 1
- 241001558929 Sclerotium <basidiomycota> Species 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 229930187719 Soyasaponin Natural products 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 208000005985 Threatened Abortion Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- IQVQXVFMNOFTMU-DHZHZOJOSA-N Z-ligustilide Natural products C1CC=CC2=C1C(=C/CCC)\OC2=O IQVQXVFMNOFTMU-DHZHZOJOSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 241000234299 Zingiberaceae Species 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 208000038016 acute inflammation Diseases 0.000 description 1
- 230000006022 acute inflammation Effects 0.000 description 1
- 210000004404 adrenal cortex Anatomy 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 1
- XCPQUQHBVVXMRQ-UHFFFAOYSA-N alpha-Fenchene Natural products C1CC2C(=C)CC1C2(C)C XCPQUQHBVVXMRQ-UHFFFAOYSA-N 0.000 description 1
- VYBREYKSZAROCT-UHFFFAOYSA-N alpha-myrcene Natural products CC(=C)CCCC(=C)C=C VYBREYKSZAROCT-UHFFFAOYSA-N 0.000 description 1
- MVNCAPSFBDBCGF-UHFFFAOYSA-N alpha-pinene Natural products CC1=CCC23C1CC2C3(C)C MVNCAPSFBDBCGF-UHFFFAOYSA-N 0.000 description 1
- 229940011037 anethole Drugs 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 230000002082 anti-convulsion Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 239000010692 aromatic oil Substances 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- QMNWISYXSJWHRY-YLNUDOOFSA-N astragaloside IV Chemical compound O1[C@H](C(C)(O)C)CC[C@]1(C)[C@@H]1[C@@]2(C)CC[C@]34C[C@]4(CC[C@H](O[C@H]4[C@@H]([C@@H](O)[C@H](O)CO4)O)C4(C)C)[C@H]4[C@@H](O[C@H]4[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)C[C@H]3[C@]2(C)C[C@@H]1O QMNWISYXSJWHRY-YLNUDOOFSA-N 0.000 description 1
- QMNWISYXSJWHRY-XZFBGSIGSA-N astragaloside a Chemical compound O1[C@H](C(C)(O)C)CC[C@]1(C)[C@@H]1[C@@]2(C)CC[C@]34C[C@]4(CC[C@H](O[C@H]4[C@@H]([C@@H](O)[C@H](O)CO4)O)C4(C)C)[C@H]4[C@@H](O[C@H]4C([C@@H](O)C(O)[C@@H](CO)O4)O)C[C@H]3[C@]2(C)C[C@@H]1O QMNWISYXSJWHRY-XZFBGSIGSA-N 0.000 description 1
- TYPSVDGIQAOBAD-UHFFFAOYSA-N atractylone Natural products C1C2(C)CCCC(=C)C2CC2=C1OC=C2C TYPSVDGIQAOBAD-UHFFFAOYSA-N 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- NKDFYOWSKOHCCO-UHFFFAOYSA-N beta-ecdysone Natural products C1C(O)C(O)CC2(C)C(CCC3(C(C(C)(O)C(O)CCC(C)(O)C)CCC33O)C)C3=CC(=O)C21 NKDFYOWSKOHCCO-UHFFFAOYSA-N 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 description 1
- 229940036350 bisabolol Drugs 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 1
- 229940116229 borneol Drugs 0.000 description 1
- 208000006218 bradycardia Diseases 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 229930006739 camphene Natural products 0.000 description 1
- ZYPYEBYNXWUCEA-UHFFFAOYSA-N camphenilone Natural products C1CC2C(=O)C(C)(C)C1C2 ZYPYEBYNXWUCEA-UHFFFAOYSA-N 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000009084 cardiovascular function Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 235000019504 cigarettes Nutrition 0.000 description 1
- KJPRLNWUNMBNBZ-UHFFFAOYSA-N cinnamic aldehyde Natural products O=CC=CC1=CC=CC=C1 KJPRLNWUNMBNBZ-UHFFFAOYSA-N 0.000 description 1
- 229940117916 cinnamic aldehyde Drugs 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 229940043350 citral Drugs 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 229960000956 coumarin Drugs 0.000 description 1
- 150000004775 coumarins Chemical class 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 229960001193 diclofenac sodium Drugs 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 239000007919 dispersible tablet Substances 0.000 description 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 229940011399 escin Drugs 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- 235000001785 ferulic acid Nutrition 0.000 description 1
- 229940114124 ferulic acid Drugs 0.000 description 1
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 1
- 210000001145 finger joint Anatomy 0.000 description 1
- 230000003890 fistula Effects 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 1
- 125000004383 glucosinolate group Chemical group 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 210000004247 hand Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- PFOARMALXZGCHY-UHFFFAOYSA-N homoegonol Natural products C1=C(OC)C(OC)=CC=C1C1=CC2=CC(CCCO)=CC(OC)=C2O1 PFOARMALXZGCHY-UHFFFAOYSA-N 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- OLOOJGVNMBJLLR-UHFFFAOYSA-N imperatorin Chemical compound C1=CC(=O)OC2=C1C=C1C=COC1=C2OCC=C(C)C OLOOJGVNMBJLLR-UHFFFAOYSA-N 0.000 description 1
- XKVWLLRDBHAWBL-UHFFFAOYSA-N imperatorin Natural products CC(=CCOc1c2OCCc2cc3C=CC(=O)Oc13)C XKVWLLRDBHAWBL-UHFFFAOYSA-N 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 208000037806 kidney injury Diseases 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- VHOGYURTWQBHIL-UHFFFAOYSA-N leflunomide Chemical compound O1N=CC(C(=O)NC=2C=CC(=CC=2)C(F)(F)F)=C1C VHOGYURTWQBHIL-UHFFFAOYSA-N 0.000 description 1
- 229960000681 leflunomide Drugs 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- YMBXTVYHTMGZDW-UHFFFAOYSA-N loxoprofen Chemical compound C1=CC(C(C(O)=O)C)=CC=C1CC1C(=O)CCC1 YMBXTVYHTMGZDW-UHFFFAOYSA-N 0.000 description 1
- 229960002373 loxoprofen Drugs 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 210000000811 metacarpophalangeal joint Anatomy 0.000 description 1
- 229940116837 methyleugenol Drugs 0.000 description 1
- PRHTXAOWJQTLBO-UHFFFAOYSA-N methyleugenol Natural products COC1=CC=C(C(C)=C)C=C1OC PRHTXAOWJQTLBO-UHFFFAOYSA-N 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 229940100243 oleanolic acid Drugs 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 239000008601 oleoresin Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- RUVINXPYWBROJD-UHFFFAOYSA-N para-methoxyphenyl Natural products COC1=CC=C(C=CC)C=C1 RUVINXPYWBROJD-UHFFFAOYSA-N 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 150000007965 phenolic acids Chemical class 0.000 description 1
- 229930195126 picroside Natural products 0.000 description 1
- KEUKDVIGAVVGLF-RUYHYXBRSA-N picroside I Natural products OC[C@]12O[C@H]1[C@@H]3O[C@@H](O[C@@H]4O[C@H](COC(=O)C=Cc5ccccc5)[C@@H](O)[C@H](O)[C@H]4O)C=C[C@@H]3[C@H]2O KEUKDVIGAVVGLF-RUYHYXBRSA-N 0.000 description 1
- AKNILCMFRRDTEY-UHFFFAOYSA-N picroside II Natural products C1=C(O)C(OC)=CC(C(=O)OC2C3C(C(OC=C3)OC3C(C(O)C(O)C(CO)O3)O)C3(CO)OC32)=C1 AKNILCMFRRDTEY-UHFFFAOYSA-N 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- KKOXKGNSUHTUBV-UHFFFAOYSA-N racemic zingiberene Natural products CC(C)=CCCC(C)C1CC=C(C)C=C1 KKOXKGNSUHTUBV-UHFFFAOYSA-N 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 208000007442 rickets Diseases 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 229910052701 rubidium Inorganic materials 0.000 description 1
- IGLNJRXAVVLDKE-UHFFFAOYSA-N rubidium atom Chemical compound [Rb] IGLNJRXAVVLDKE-UHFFFAOYSA-N 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- JGMJQSFLQWGYMQ-UHFFFAOYSA-M sodium;2,6-dichloro-n-phenylaniline;acetate Chemical compound [Na+].CC([O-])=O.ClC1=CC=CC(Cl)=C1NC1=CC=CC=C1 JGMJQSFLQWGYMQ-UHFFFAOYSA-M 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 208000012271 tenesmus Diseases 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 108010058651 thioglucosidase Proteins 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- AQWHMKSIVLSRNY-UHFFFAOYSA-N trans-Octadec-5-ensaeure Natural products CCCCCCCCCCCCC=CCCCC(O)=O AQWHMKSIVLSRNY-UHFFFAOYSA-N 0.000 description 1
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 1
- 150000008130 triterpenoid saponins Chemical class 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 229940096998 ursolic acid Drugs 0.000 description 1
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 210000000707 wrist Anatomy 0.000 description 1
- 229910052727 yttrium Inorganic materials 0.000 description 1
- VWQVUPCCIRVNHF-UHFFFAOYSA-N yttrium atom Chemical compound [Y] VWQVUPCCIRVNHF-UHFFFAOYSA-N 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000001841 zingiber officinale Substances 0.000 description 1
- KKOXKGNSUHTUBV-LSDHHAIUSA-N zingiberene Chemical compound CC(C)=CCC[C@H](C)[C@H]1CC=C(C)C=C1 KKOXKGNSUHTUBV-LSDHHAIUSA-N 0.000 description 1
- 229930001895 zingiberene Natural products 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/24—Mucus; Mucous glands; Bursa; Synovial fluid; Arthral fluid; Excreta; Spinal fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/235—Foeniculum (fennel)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/237—Notopterygium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/238—Saposhnikovia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/714—Aconitum (monkshood)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention belongs to the technical field of traditional Chinese medicines, and discloses a composition for treating gout and rheumatoid osteoarthritis and a preparation method thereof. The composition is prepared from astragalus root, white atractylodes rhizome, poria cocos, chamomile, honey-fried licorice root, notopterygium root, ledebouriella root, schizophragma integrifolia, achyranthes root, Ligusticum wallichii, Bupleurum root, trogopterus dung, myrrh, white mustard seed, fried fennel, dried ginger, cassia bark and prepared aconite root in optimum proportion. In the formula, the astragalus has the effects of tonifying spleen and middle warmer, lifting yang and sinking, benefiting defense and consolidating exterior, promoting urination, removing toxin and promoting granulation; bai Zhu, drying dampness and inducing diuresis; poria, with the effects of inducing diuresis to alleviate edema, and optionally flos Chrysanthemi, radix Glycyrrhizae Preparata, Notopterygii rhizoma, radix Saposhnikoviae, cortex Schizophragmatis Integrifolii Radicis, Achyranthis radix, rhizoma Ligustici Chuanxiong, bupleuri radix, Oletum Trogopterori, Myrrha, semen Sinapis Albae, parched fructus Foeniculi, Zingiberis rhizoma, cortex Cinnamomi Japonici and radix Aconiti lateralis Preparata. The composition is a complete prescription, and has effects of activating qi-flowing, resolving stagnation, clearing heat, eliminating dampness, dispelling pathogenic wind, promoting blood circulation and removing blood stasis. The preparation method of the composition is simple and convenient, and the obtained finished product has stable dosage form and is convenient to take.
Description
Technical Field
The invention belongs to the technical field of traditional Chinese medicines, and particularly relates to a composition for treating gout and rheumatoid osteoarthritis and a preparation method thereof.
Background
Gout is caused by the fact that the uric acid content in a patient is increased sharply, and the gout belongs to the disease of middle-dampness in traditional Chinese medicine. Moisture enters the joint marrow and the patient experiences sudden severe pain in one or more joints. The disease usually occurs suddenly at night, and the joint is red, swollen, hot and painful.
Rheumatism is caused in the bone and enters the bone marrow. Pain is intolerable, hands and feet are dragged, waist ridge is 20251, and rachitis cannot be got up in the bed in the year of age and cannot be obtained. The bony prominences present hard tophus agglomerates.
Rheumatoid arthritis, which is less painful than gout, occurs between the condyloma. The finger interphalangeal joints, metacarpophalangeal joints, wrist and other small joints are the first to get ill, morning stiffness, swelling, pain and serious deformity of joints.
The common characteristics of the two diseases are as follows: lesions all occur in the bone. One in the bone marrow and one in the condyle. In TCM, kidneys govern bones, so both diseases are directly related to kidneys. Wind-dampness enters meridians and collaterals easily and is difficult to remove. Since bone marrow belongs to kidney, kidney can tonify but not discharge, wind-damp can hurt kidney, kidney injury can prevent qi from being weakened, so it can not be eliminated.
Therefore, both of the above diseases are difficult to treat, and the common drugs for treating rheumatism hardly reach the focus of infection, so the treatment of the disease is very difficult. However, kidneys cannot discharge. However, there is a therapy called "fu-borrowing therapy" in traditional Chinese medicine. That is, other viscera can be used to replace renal purging therapy to eliminate rheumatism in bone marrow. This problem is readily solved.
Disclosure of Invention
In order to solve the problems in the prior art, the invention aims to provide a composition for treating gout and rheumatoid osteoarthritis and a preparation method thereof.
The technical scheme adopted by the invention is as follows: the composition for treating gout and rheumatoid osteoarthritis is mainly prepared from the following raw materials in parts by mass:
10-40 parts of astragalus membranaceus, 5-20 parts of bighead atractylodes rhizome, 5-20 parts of poria cocos, 3-12 parts of chamomile, 0.5-4 parts of honey-fried licorice root, 0.5-2 parts of notopterygium root, 0.5-2 parts of divaricate saposhnikovia root, 5-15 parts of schizophragma integrifolium, 5-15 parts of achyranthes root, 0.3-6 parts of ligusticum wallichii, 0.5-4 parts of radix bupleuri, 0.3-6 parts of trogopterus dung, 0.3-6 parts of myrrh, 3-12 parts of semen brassicae, 0.03-0.1 part of fried fennel, 0.25-1 part of rhizoma zingiberis, 0.5-4 parts of cinnamon and 0.1-0.5 part of monkshood.
Astragalus root, name of traditional Chinese medicine. Is root of Astragalus membranaceus (Fisch.) Bge. of Astragalus of Leguminosae, Astragalus membranaceus (Astragalus membranaceus) Astragalus Memeranaceus (Var.) Bge. Hsiao or Astragalus membranaceus (Fisch.) Bge. Has effects in invigorating spleen, strengthening middle warmer, invigorating yang, lifting sink, invigorating defensive qi, consolidating superficial resistance, promoting urination, removing toxic materials, and promoting granulation. It is mainly indicated for spleen qi deficiency syndrome, lung qi deficiency syndrome, qi deficiency spontaneous sweating syndrome, qi and blood deficiency, ulcer and sore difficult to ulcerate and rot, or difficult to heal for a long time. Sweet in flavor and slightly warm in nature; it enters spleen and lung meridians. Chemical components: separating astragaloside I, astragaloside II, daucosterol, beta-sitosterol, palmitic acid, astragaloside A, B, C, 2', 4' -dihydroxy-5, 6-dimethoxy isoflavan, ursolic acid, choline, betaine, folic acid, calycosin, formononetin and astragaloside I, II, III, IV using triterpene cycloastragaloside as aglycone from radix astragali. The antibacterial component is L-3-hydroxy-9-methoxyl pterocarpan. The Mongolian radix astragali contains soyasaponin, astragalosides I, II, IV, and daucosterol. Contains three kinds of homogeneous polysaccharides including astragalus polysaccharide I, astragalus polysaccharide II and astragalus polysaccharide III, and has two kinds of dextran AG-1 and AG-2 separated and two kinds of heteropolysaccharide AH-l and AH-2 separated. AG-1 and AH-1 have immune promoting effect. Contains flavonoids such as formononetin and calycosin; it also contains 21 amino acids such as asparagine, canavanine, proline and Yttrium, etc., and 14 trace elements such as iron, manganese, zinc and rubidium.
Baizhu, name of Chinese medicine. Is rhizome of Atractylodes macrocephala Koidz of Atractylodes of Compositae. Has effects of invigorating qi, invigorating spleen, eliminating dampness, promoting diuresis, arresting sweating, and preventing miscarriage. It can be used for treating deficiency of spleen-qi, spleen deficiency, stagnation of spleen-qi, spleen deficiency, fluid retention, excessive sweat due to muscle surface weakness, and threatened abortion. Bitter and sweet in taste and warm in nature; it enters spleen and stomach meridians. Chemical components: the Atractylodis rhizoma contains volatile oil, and the oil mainly contains atractylone, atractylenolide A, B and saccharide (mainly mannose and fructose).
Tuckahoe, name of traditional Chinese medicine. Is dried sclerotium of Wolf of Poriacos (Schw.) of Polyporaceae family. Yun Ling is called Yun Ling in Yunnan province, and is superior in quality. Has effects of inducing diuresis to alleviate edema, eliminating dampness, invigorating spleen, and calming heart. It can be used for treating edema, phlegm retention, diarrhea due to spleen deficiency, palpitation, and insomnia. Sweet and light taste, mild in nature; it enters heart, lung and spleen meridians.
The chamomile belongs to the family of compositae, is slightly bitter and sweet in taste, has the effects of helping sleep and moistening skin, and can also improve premenstrual discomfort of women. It can be used for relieving soreness, liver fire, and eye fatigue. Can be used for treating constipation, relieving tension and eye fatigue, moistening lung, and promoting health. Is beneficial to liver function maintenance, nervosity and spasm. Can be used for relieving muscular soreness and migraine caused by common cold, and has beneficial effect on stomach and abdominal nerve. Improving eyesight, clearing liver fire, treating insomnia, lowering blood pressure, improving vitality, and refreshing mind. Improving memory and reducing cholesterol. Scientists found antioxidants and some elements that inhibit microbial growth in camomile oil.
Radix Glycyrrhizae Preparata is a plant of Leguminosae, and is baked with Mel. Radix Glycyrrhizae Preparata contains glycyrrhizin, glycyrrhetinic acid, and Glycyrrhiza polysaccharide, and has antiinflammatory, antiallergic, immunity regulating, antitumor, and analgesic effects. Therefore, the main effects of honey-fried licorice root are to harmonize the middle warmer, relieve urgency, moisten lung, remove toxicity, and harmonize the other drugs. It is commonly indicated for weakness of spleen and stomach, lassitude, palpitation and intermittent pulse, and can relieve subsidiary toxicity. The clinical application of radix Glycyrrhizae Preparata is mostly radix Glycyrrhizae Preparata decoction, which is prepared from radix Glycyrrhizae Preparata as main raw material. Therefore, the efficacy and action of gan-ji-gan-Cao can be analyzed from gan-ji-gan-Cao decoction. According to doctors of all generations, the main effects and actions of the honey-fried licorice decoction are considered as four points, namely the effect of nourishing yin, the effect of replenishing blood, the effect and action of tonifying qi and blood, and the coordination of yin and yang.
Notopterygium root, rhizoma Et radix Notopterygii, the name of Chinese medicine. Is rhizome and root of Notopterygium inccisum Ting ex H.T. Chang or Notopterygium forbesii Boiss. Has the effects of relieving exterior syndrome, dispelling cold, dispelling pathogenic wind, eliminating dampness, and relieving pain. It can be used for treating wind-cold type common cold and arthralgia due to wind-cold-dampness. Pungent and bitter taste, warm nature; it enters bladder and kidney meridians. Chemical components: the product contains volatile oil, beta-sitosterol, coumarin compound, phenolic compound, daucosterol, imperatorin, organic acid and alkaloid.
Ledebouriella root, radix Saposhnikoviae, 5-10g of Chinese medicine. Is root of Saposhnikovia divaricata (Turcz.) Schischk. of Saposhnikovia of Umbelliferae. Has the effects of dispelling pathogenic wind, relieving exterior syndrome, eliminating dampness, relieving pain, and relieving spasm. It can be used for treating exterior syndrome due to exogenous pathogenic factors, rubella pruritus, rheumatalgia, and tetanus. Pungent and sweet in flavor and slightly warm in nature; it enters bladder and liver meridians. Chemical components: the product contains volatile oil, mannitol, beta-sitosterol, picroside, phenols, polysaccharides, organic acids, etc. The pharmacological action is as follows: the product has antipyretic, antiinflammatory, tranquilizing, analgesic, anticonvulsive, and antiallergic effects. The divaricate saposhnikovia root fresh juice has a certain antibacterial effect on pseudomonas aeruginosa and staphylococcus aureus, the decoction has different degrees of inhibition effects on dysentery bacillus, hemolytic streptococcus and the like, and the decoction has the effect of enhancing the phagocytic function of abdominal cavity macrophages of mice.
The name of the traditional Chinese medicine is Zuangfeng. Is root and stem of Schizophragmatergrifolia (Franch.) Oliv. of Saxifragaceae. Is distributed in southwest, Shaanxi, Anhui, Zhejiang, Jiangxi, Fujian, Taiwan, Hubei, Hunan, Guangdong, Guangxi, etc. Has the effects of relaxing muscles and tendons, activating collateral flow, expelling pathogenic wind, and promoting blood circulation. It is commonly used for arthralgia due to wind-dampness and soreness of joints of limbs. Bland in flavor and cool in nature. It enters spleen meridian. The pharmacological action is as follows: 1. can inhibit influenza virus. 2. Can increase blood sugar.
Achyranthes bidentata, the name of Chinese medicine. Is prepared from radix Achyranthis bidentatae (Achyranthus bidentata) BI. of Achyranthus of Amaranthaceae and radix Cyathulae (sweet Achyranthes bidentata) Cyathula officinalis Kuan of Cyathula officinalis of Cyathula of Amaranthaceae. Has the effects of promoting blood circulation, stimulating the menstrual flow, tonifying liver and kidney, strengthening muscles and bones, inducing diuresis, treating stranguria and guiding fire (blood) downwards. It can be used for treating amenorrhea, dysmenorrhea, abdominal pain during menstruation, retained afterbirth, traumatic injury, soreness of waist and knees, debility and weakness of lower limbs, stranguria, edema, dysuria, headache, vertigo, toothache, aphtha of the mouth and tongue, hematemesis, and epistaxis. Bitter, sweet and sour in taste and mild in nature; it enters liver and kidney meridians. Chemical components: radix Achyranthis contains triterpenoid saponin (prepared by hydrolyzing to oleanolic acid and sugar), ecdysterone, inocosterone, and radix Achyranthis bidentatae sterone, and polysaccharides. In addition, Achyranthis radix also contains 12 amino acids such as arginine, alkaloids, coumarins, and trace elements such as iron and copper.
Rhizoma Ligustici Chuanxiong, named as Chinese medicine, is dried rhizome of Ligusticum chuanxiong Hort. Has effects of promoting blood circulation, activating qi-flowing, dispelling pathogenic wind and relieving pain. It is mainly used for treating thoracic obstruction and heart pain due to heart vessel stagnation, hypochondriac distending pain due to liver depression and qi stagnation, chest and hypochondriac pricking pain due to liver blood stagnation, traumatic injury due to blood stasis, pyocutaneous disease and swelling pain, menoxenia, amenorrhea and dysmenorrhea, puerperal blood stasis and pain, lochiorrhea, various headaches and rheumatism pain. Pungent taste and warm nature; it enters liver, gallbladder and pericardium meridians. Chemical components: the product contains alkaloid (such as ligustrazine), volatile oil (mainly including ligustilide and cholestene), phenolic substance (such as ferulic acid), lactone, vitamin A, folic acid, sucrose, sterol, fatty oil, etc.
Bupleurum root, the name of Chinese medicine. Is dried root of Bupleurum chinense DC or Bupleurum scorzonerifolium Willd. Has the effects of relieving exterior syndrome, relieving fever, dispersing stagnated liver qi for relieving qi stagnation, and lifting yang qi. It is mainly used for treating exterior syndrome fever, shaoyang syndrome, liver depression and qi stagnation, qi deficiency sinking, organ prolapse, fever abatement and malaria interception. Bitter and pungent taste, slightly cold nature; it enters liver and gallbladder meridians. Chemical components: radix bupleuri contains alpha-spinasterol, chaenomeles alcohol, saikoside a, c and d, and volatile oil. Radix bupleuri chinensis contains saikoside a, c, d, volatile oil, bupleurum alcohol, chaulmoogra alcohol, alpha-spinasterol, etc.
Trogopterus dung, the name of traditional Chinese medicine. Dried feces of the Trogopterus xanthipes Milne-Edwards, which is a compound-rodent Trogopterus xanthipes of the family Trogopterus. Has effects of promoting blood circulation, relieving pain, removing blood stasis, and stopping bleeding. It can be used for treating pain due to blood stasis, such as thoracic obstruction, heart pain, hypochondriac pain, dysmenorrhea, amenorrhea, puerperal abdominal pain due to blood stasis, fracture, and hemorrhage due to blood stasis and blood stasis. Bitter, salty and sweet in taste, warm in nature; it enters liver meridian. Chemical components: contains triterpenes (such as triterpenic acid, trogopterus dung triterpenic acid, etc.), phenolic acid, nitrogen-containing compounds (urea, uric acid), vitamin A substances, and resin.
Myrrh, name of traditional Chinese medicine. Is oleoresin exuded from bark of Commiphora myrrha Engl. or other plants of the same genus of Commiphora of Burseraceae. Has effects of promoting blood circulation, relieving pain, eliminating swelling, and promoting granulation. Can be used for treating traumatic injury, swelling and pain due to blood stasis, carbuncle, cellulitis, swelling and pain, unhealed skin ulcer, chest pain, hypochondriac pain, cardialgia, dysmenorrhea, puerperal abdominal pain, rheumatalgia, and abdominal mass. Pungent, bitter and neutral in flavor; it enters heart, liver and spleen meridians. Chemical components: comprises Myrrha resin, volatile oil (eugenol, etc.), gum, small amount of bitter substances, and also comprises bisabolol, formic acid, acetic acid, oxidase, etc.
White mustard seed, the name of traditional Chinese medicine. Is seed of Brassicaceae plant Sinapis alba L. Has effects of warming lung, eliminating phlegm, activating qi-flowing, resolving hard mass and relieving swelling. It is mainly used for treating cold phlegm cough and asthma, fluid retention, dorsal furuncle, multiple abscess, numbness of limbs, and arthralgia. Pungent taste and warm nature; it enters lung and stomach meridians. Chemical components: the seeds contain glucosinolates and are filled with sinapioside. It also contains fatty oil, myrosinase, sinapine and lysine, arginine, histidine, etc. Also contains 4-hydroxybenzoyl choline and 4-hydroxybenzyl methylamine.
Parched fructus Foeniculi is dried mature fruit of Foeniculum vulgare of Umbelliferae. Fruits (fennel) are used as spices and also as pharmaceuticals, and roots, leaves, and herbs can be used as medicines. The name of the traditional Chinese medicine. Is dried mature fruit of Foeniculum vulgare Mill of Foeniculum of Umbelliferae. Has effects in warming kidney and liver, promoting qi circulation, relieving pain, and regulating stomach function. It can be used for treating abdominal pain due to hernia of cold type, testis tenesmus, abdominal psychroalgia, anorexia, vomiting, diarrhea, hypochondriac pain, lumbago due to kidney deficiency, and dysmenorrhea. Pungent taste and warm nature; it enters liver, kidney, bladder and stomach meridians. Chemical components: contains volatile oil 3-6% and trans-anethole, limonene, fenchyl ketone, estragole, gamma-terpinene, alpha-pinene, myrcene, etc. as main components. The fat oil contains about 18% of fatty acid, wherein the fatty acid mainly comprises petroselinic acid, oleic acid, linoleic acid, palmitic acid, arachidic acid and the like. And contains small amount of anethole, anisaldehyde, etc.
Dried ginger, named as traditional Chinese medicine. Is dried rhizome of Zingiber officinale Rosc. of Zingiberaceae. Has the effects of warming spleen and stomach for dispelling cold, restoring yang and dredging collaterals, and warming lung and resolving fluid retention. It can be used for treating abdominal psychroalgia, emesis, diarrhea, yang exhaustion, cough and asthma due to cold-fluid retention, and arthralgia due to cold-dampness. Pungent taste and hot property; it enters spleen, stomach, heart and lung meridians. Chemical components: contains volatile oil about 2%, and mainly contains zingiberene, phellandrene, camphene, zingiberone, gingerol, zingiberone, borneol, gingerol, citral, etc. It also contains resin, starch and amino acids. The pharmacological action is as follows: rhizoma Zingiberis has tranquilizing, analgesic, antiinflammatory, anticoagulant, anoxia resisting, and other effects, and has effects on cardiovascular function, adrenal cortex function, and digestive system.
Cinnamon, also known as cinnamon, cinnamon bark or cinnamon bark, is the general name given to the bark of Cinnamomum japonicum, Cinnamomum cassia or Cinnamomum cassia of Lauraceae. The product is a common traditional Chinese medicine, and is also a food spice or a cooking seasoning. Aromatic oil or cassia oil can be extracted from plant parts such as bark, branch, leaf, fruit and flower stalk, and can be used in food, beverage, cigarette and medicine, but is often used as essence for spice, cosmetics and daily necessities. The oil yield of bark is 2.15%, the oil yield of cassia twig is 0.35%, the oil yield of cassia leaf is 0.39%, and the oil yield of cassia seed (young fruit) is 2.04%. The bark is called cinnamon. The bark of Cinnamomum japonicum contains volatile oil about 1%, and contains phellandrene, eugenol, and methyl eugenol. The leaf contains about 1% of volatile oil, about 60% of safrole, about 3% of eugenol, 1, 8-escin and the like. The bark of the cinnamomum tenuifolia contains about 1% of volatile oil and 12.8% of tannin. The leaf contains about 1% volatile oil. The seeds contain 40% of fatty oil. The pharmacological effects of cinnamaldehyde and eugenol contained in cortex Cinnamomi include cortex Cinnamomi and flos Caryophylli strip. Cinnamon bark, cortex Cinnamomi, pungent and sweet in flavor, warmly retention, enters kidney, spleen and bladder meridians. Has effects of invigorating primordial qi, warming spleen and stomach, removing cold accumulation, dredging collaterals, relieving pain and relieving diarrhea. It can be used for treating decline of vital gate fire, cold limbs, slight pulse, yang exhaustion, asthenia, abdominal pain, diarrhea, hernia, cold pain of waist and knee, yin gangrene and multiple abscess through cortex Cinnamomi Japonici (side surface), and floating yang. The pharmacological action is as follows: 1. warming kidney and strengthening yang: can be used for treating intolerance of cold due to kidney yang deficiency, cold limbs, cold pain of waist and knee joint, and asthenic asthma and adverse rising of qi due to kidney failure to receive qi; 2. warming middle energizer to dispel cold: for cold pain in the stomach and abdominal pain and diarrhea due to deficiency-cold of spleen and stomach, it is often combined with gan Jiang and Fu Zi to relieve pain in 3, warm meridians and alleviate pain: has effects in warming and dredging blood vessels, dispelling cold, and relieving pain, and can be used for treating dysmenorrhea and limb pain caused by cold accumulation and qi stagnation. The product is pungent, sweet and hot, pure yang with dryness and strong heat, and good at warming the middle-jiao and the lower-jiao to dispel cold and alleviate pain, and red color enters blood to promote qi and blood growth, so it is the essential herb for spleen-kidney yang deficiency, cold accumulation and pain, deficiency-cold of qi and blood, etc.
Radix Aconiti lateralis, also known as Aconitum carmichaeli or aconite, also known as Aconitum kusnezoffii, Aconitum carmichaeli, herba Centipedae, flos Ferulae, WUDU, Latin Wen name: aconitum carmichaeli Debx is processed product of seed root of Aconitum plant of Ranunculaceae. Mainly produced in Sichuan, Hubei, Hunan, etc. of China. Collected in the late 6 th to the early 8 th of the month, and the mother root, fibrous root and silt are removed, which is called as "mud Fu Zi". Processing into salty radix Aconiti lateralis Preparata, black radix Aconiti lateralis Preparata, rhizoma Typhonii, radix Aconiti lateralis Preparata, and processed radix Aconiti lateralis. It belongs to interior-warming herbs. The first product of rescuing from collapse by restoring yang in Chinese herbs. The functional indications are as follows: reviving yang and rescuing from collapse, tonifying fire and supporting yang, dispelling cold and relieving pain. It is indicated for yang deficiency due to exuberant yin, profuse sweat, yang exhaustion, vomiting, syncope, psychroalgia of heart and abdomen, diarrhea and dysentery of spleen, beriberi, edema, infantile chronic convulsion, arthralgia due to wind-cold-dampness, lame spasm, impotence, cold womb, carbuncle of yin, ulcer and fistula, and all the diseases of cold pertinence. The pharmacological action is as follows: the radix Aconiti lateralis has effects of increasing myocardial contraction force, increasing heart rate, increasing cardiac output, and increasing oxygen consumption of myocardium. Radix Aconiti lateralis has effects of dilating blood vessel, increasing blood flow, and improving blood circulation. The effect of Fu Zi on blood pressure is both pressure-increasing and pressure-lowering, and is related to its components. The effect of Fu Zi for restoring yang and treating mainly is based on the action of heart-strengthening to resist shock. The monkshood has obvious effect of resisting bradyarrhythmia. The aconite decoction has obvious inhibition effect on acute inflammation models.
Preferably, the composition is mainly prepared from the following raw materials in parts by mass:
15-38 parts of astragalus membranaceus, 10-18 parts of bighead atractylodes rhizome, 10-18 parts of poria cocos, 5-10 parts of chamomile, 1-3 parts of honey-fried licorice root, 0.8-1.5 parts of notopterygium root, 0.8-1.5 parts of divaricate saposhnikovia root, 8-12 parts of schizophragma integrifolium, 8-12 parts of radix achyranthis bidentatae, 1-4 parts of ligusticum wallichii, 1-3 parts of radix bupleuri, 1-4 parts of trogopterus dung, 1-4 parts of myrrh, 5-8 parts of semen brassicae, 0.05-0.08 part of fried fennel, 0.5-0.8 part of dried ginger, 1-3 parts of cinnamon and 0.2-0.4 part of monkshood.
Preferably, the composition is mainly prepared from the following raw materials in parts by mass:
30 parts of astragalus membranaceus, 15 parts of bighead atractylodes rhizome, 15 parts of poria cocos, 8 parts of chamomile, 2 parts of honey-fried licorice root, 1 part of notopterygium root, 1 part of divaricate saposhnikovia root, 10 parts of schizophragma integrifolium, 10 parts of achyranthes root, 3 parts of ligusticum wallichii, 2 parts of radix bupleuri, 3 parts of trogopterus dung, 3 parts of myrrh, 6 parts of semen brassicae, 0.06 part of fried fennel, 0.6 part of dried ginger, 2 parts of cinnamon and 0.3 part of monkshood.
The monkshood used in the formula is not raw monkshood but prepared monkshood. The dose of prepared aconite is small, only 0.5 g, and actually each dose is only 0.0125 g. Therefore, the toxicity is completely negligible, and the safety is absolute. Moreover, the licorice root can detoxify the aconite root, so the Chinese medicinal preparation is safe and reliable. Furthermore, the treatment is taken only 10 days to the right, and is not taken for a long time.
Preferably, the composition is a pill or liquid formulation.
A preparation method of a composition for treating gout and rheumatoid osteoarthritis comprises the following steps when the composition is a pill: selecting radix astragali, Atractylodis rhizoma, Poria, flos Chrysanthemi, radix Glycyrrhizae Preparata, Notopterygii rhizoma, radix Saposhnikoviae, cortex Schizophragmatis Integrifolii Radicis, Achyranthis radix, rhizoma Ligustici Chuanxiong, bupleuri radix, Oletum Trogopterori, Myrrha, semen Sinapis Albae, parched fructus Foeniculi, Zingiberis rhizoma, cortex Cinnamomi Japonici and radix Aconiti lateralis according to corresponding proportion, mixing, pulverizing, sieving, adding solvent, and mixing to obtain pill.
Preferably, the astragalus, the bighead atractylodes rhizome, the poria cocos, the chamomile, the honey-fried licorice root, the notopterygium root, the divaricate saposhnikovia root, the schizophragma integrifolia, the achyranthes root, the szechuan lovage rhizome, the radix bupleuri, the trogopterus dung, the myrrh, the white mustard seed, the fried fennel, the dried ginger, the cassia bark and the monkshood are selected, mixed, crushed and sieved by a 800-mesh and 1000-mesh sieve.
Preferably, the solvent is a mixture of water and honey;
the proportion of the water and the honey is 0.3-0.8 wt%: 0.2-0.7 wt%;
the weight ratio of the total mass of the mixed astragalus, bighead atractylodes rhizome, poria cocos, chamomile, honey-fried licorice root, notopterygium root, divaricate saposhnikovia root, schizophragma integrifolia, achyranthes root, szechuan lovage rhizome, Chinese thorowax root, trogopterus dung, myrrh, white mustard seed, fried fennel, dried ginger, cassia bark and monkshood to the solvent is 1: 0.5-0.8 wt%.
A preparation method of a composition for treating gout and rheumatoid osteoarthritis comprises the following steps when the composition is a liquid preparation: selecting radix astragali, rhizoma Atractylodis Macrocephalae, Poria, flos Chrysanthemi, radix Glycyrrhizae Preparata, rhizoma Et radix Notopterygii, radix Saposhnikoviae, cortex schizophragmatis integrifolii radicis, radix Achyranthis bidentatae, rhizoma Chuanxiong, radix bupleuri, Oletum Trogopterori, Myrrha, semen Sinapis, parched fructus Foeniculi, rhizoma Zingiberis, cortex cinnamomi japonici, and radix Aconiti lateralis Preparata according to a certain proportion, mixing, soaking, decocting, and filtering to remove residues to obtain a liquid preparation.
Preferably, the soaking is performed by using water, and the soaking time is 20-30 minutes.
Preferably, the decoction temperature is 80-90 ℃; the decoction time is 30-55 minutes.
The invention has the beneficial effects that:
the invention provides a composition for treating gout and rheumatoid osteoarthritis, which is prepared from astragalus root, white atractylodes rhizome, poria cocos, chamomile, honey-fried licorice root, notopterygium root, ledebouriella root, schizophragma integrifolium, achyranthes root, Ligusticum wallichii, Bupleurum root, trogopterus dung, myrrh, white mustard seed, stir-fried fennel fruit, dried ginger, cassia bark and prepared aconite root in optimum proportion.
In the formula, the astragalus has the effects of tonifying spleen and middle warmer, lifting yang and sinking, benefiting defense and consolidating exterior, promoting urination, removing toxin and promoting granulation; bai Zhu, drying dampness and inducing diuresis; poria, with the effects of inducing diuresis to alleviate edema, and optionally flos Chrysanthemi, radix Glycyrrhizae Preparata, Notopterygii rhizoma, radix Saposhnikoviae, cortex Schizophragmatis Integrifolii Radicis, Achyranthis radix, rhizoma Ligustici Chuanxiong, bupleuri radix, Oletum Trogopterori, Myrrha, semen Sinapis Albae, parched fructus Foeniculi, Zingiberis rhizoma, cortex Cinnamomi Japonici and radix Aconiti lateralis Preparata. The composition is a complete prescription, and has effects of activating qi-flowing, resolving stagnation, clearing heat, eliminating dampness, dispelling pathogenic wind, promoting blood circulation and removing blood stasis.
The preparation method of the composition is simple and convenient, and the obtained finished product has stable dosage form and is convenient to take.
Detailed Description
The present invention is further illustrated below with reference to specific examples. It will be appreciated by those skilled in the art that the following examples, which are set forth to illustrate the present invention, are intended to be part of the present invention, but not to be construed as limiting the scope of the present invention. The reagents used are all conventional products which are commercially available.
Example 1:
a preparation method of a composition for treating gout and rheumatoid osteoarthritis comprises the following steps when the composition is a pill: selecting 10g of astragalus root, 5 g of white atractylodes rhizome, 5 g of tuckahoe, 3 g of chamomile, 0.5 g of honey-fried licorice root, 0.5 g of notopterygium root, 0.5 g of ledebouriella root, 5 g of schizophragma integrifolium, 5 g of achyranthes root, 0.3 g of rhizoma ligustici wallichii, 0.5 g of radix bupleuri, 0.3 g of trogopterus dung, 0.3 g of myrrh, 3 g of white mustard seed, 0.03 g of fried fennel, 0.25 g of dried ginger, 0.5 g of cassia bark and 0.1 g of monkshood according to corresponding proportion, mixing, crushing, sieving by a 800-mesh sieve, adding 9.55 g of water and 22.3 g of honey, and uniformly mixing to obtain the finished product pill.
A preparation method of a composition for treating gout and rheumatoid osteoarthritis comprises the following steps when the composition is a liquid preparation: selecting 10g of astragalus root, 5 g of white atractylodes rhizome, 5 g of tuckahoe, 3 g of chamomile, 0.5 g of honey-fried licorice root, 0.5 g of notopterygium root, 0.5 g of ledebouriella root, 5 g of schizophragma integrifolium, 5 g of achyranthes root, 0.3 g of rhizoma ligustici wallichii, 0.5 g of radix bupleuri, 0.3 g of trogopterus dung, 0.3 g of myrrh, 3 g of white mustard seed, 0.03 g of fried fennel, 0.25 g of dried ginger, 0.5 g of cassia bark and 0.1 g of monkshood according to corresponding proportion, mixing, soaking for 20 minutes, decocting for 30 minutes at 80 ℃, filtering residues, and obtaining the finished product liquid preparation.
Example 2:
a preparation method of a composition for treating gout and rheumatoid osteoarthritis comprises the following steps when the composition is a pill: selecting 40 g of astragalus root, 20 g of largehead atractylodes rhizome, 20 g of tuckahoe, 12 g of chamomile, 4 g of honey-fried licorice root, 2 g of notopterygium root, 2 g of divaricate saposhnikovia root, 15 g of schizophragma integrifolium, 15 g of twotooth achyranthes root, 6 g of szechuan lovage rhizome, 4 g of radix bupleuri, 6 g of trogopterus dung, 6 g of myrrh, 12 g of white mustard seed, 0.1 g of fried fennel, 1 g of dried ginger, 4 g of cassia bark and 0.5 g of monkshood according to corresponding proportion, mixing, crushing, sieving by a 1000-mesh sieve, adding 42.4 g of water and 42.4 g of honey, and uniformly mixing to obtain the finished pill.
A preparation method of a composition for treating gout and rheumatoid osteoarthritis comprises the following steps when the composition is a liquid preparation: selecting 40 g of astragalus root, 20 g of bighead atractylodes rhizome, 20 g of poria cocos, 12 g of chamomile, 4 g of honey-fried licorice root, 2 g of notopterygium root, 2 g of divaricate saposhnikovia root, 15 g of schizophragma integrifolium, 15 g of achyranthes root, 6 g of ligusticum wallichii, 4 g of radix bupleuri, 6 g of trogopterus dung, 6 g of myrrh, 12 g of semen brassicae, 0.1 g of fried fennel, 1 g of dried ginger, 4 g of cassia bark and 0.5 g of monkshood according to corresponding proportion, mixing, soaking for 30 minutes, decocting for 55 minutes at 90 ℃, and filtering residues to obtain a finished liquid preparation.
Example 3:
a preparation method of a composition for treating gout and rheumatoid osteoarthritis comprises the following steps when the composition is a pill: selecting 15 g of astragalus root, 10g of white atractylodes rhizome, 10g of tuckahoe, 5 g of chamomile, 1 g of honey-fried licorice root, 0.8 g of notopterygium root, 0.8 g of divaricate saposhnikovia root, 8 g of schizophragma integrifolium, 8 g of achyranthes root, 1 g of szechuan lovage rhizome, 1 g of radix bupleuri, 1 g of trogopterus dung, 1 g of myrrh, 5 g of white mustard seed, 0.05 g of fried fennel, 0.5 g of dried ginger, 1 g of cassia bark and 0.2 g of monkshood according to corresponding proportion, mixing, crushing, sieving by a 800-mesh sieve, adding 44.38 g of water and 11.1 g of honey, and uniformly mixing to obtain the finished pill.
A preparation method of a composition for treating gout and rheumatoid osteoarthritis comprises the following steps when the composition is a liquid preparation: selecting 15 g of astragalus root, 10g of white atractylodes rhizome, 10g of tuckahoe, 5 g of chamomile, 1 g of honey-fried licorice root, 0.8 g of notopterygium root, 0.8 g of divaricate saposhnikovia root, 8 g of schizophragma integrifolium, 8 g of achyranthes root, 1 g of szechuan lovage rhizome, 1 g of radix bupleuri, 1 g of trogopterus dung, 1 g of myrrh, 5 g of white mustard seed, 0.05 g of fried fennel, 0.5 g of dried ginger, 1 g of cassia bark and 0.2 g of monkshood according to corresponding proportion, mixing, soaking for 20 minutes, decocting for 55 minutes at 90 ℃, and filtering residues to obtain a finished liquid preparation.
Example 4:
a preparation method of a composition for treating gout and rheumatoid osteoarthritis comprises the following steps when the composition is a pill: selecting 38 g of astragalus root, 18 g of bighead atractylodes rhizome, 18 g of poria cocos, 10g of chamomile, 3 g of honey-fried licorice root, 1.5 g of notopterygium root, 1.5 g of divaricate saposhnikovia root, 12 g of schizophragma integrifolium, 12 g of achyranthes root, 4 g of ligusticum wallichii, 3 g of radix bupleuri, 4 g of trogopterus dung, 4 g of myrrh, 8 g of semen brassicae, 0.08 g of fried fennel, 0.8 g of dried ginger, 3 g of cassia bark and 0.4 g of monkshood according to corresponding proportion, mixing, crushing, sieving by a 1000-mesh sieve, adding 56.5 g of water and 56.5 g of honey, and uniformly mixing to obtain the finished pill.
A preparation method of a composition for treating gout and rheumatoid osteoarthritis comprises the following steps when the composition is a liquid preparation: selecting 38 g of astragalus, 18 g of bighead atractylodes rhizome, 18 g of poria cocos, 10g of chamomile, 3 g of honey-fried licorice root, 1.5 g of notopterygium root, 1.5 g of divaricate saposhnikovia root, 12 g of schizophragma integrifolium, 12 g of achyranthes root, 4 g of ligusticum wallichii, 3 g of radix bupleuri, 4 g of trogopterus dung, 4 g of myrrh, 8 g of semen brassicae, 0.08 g of fried fennel, 0.8 g of dried ginger, 3 g of cassia bark and 0.4 g of monkshood according to corresponding proportions, mixing, soaking for 30 minutes, decocting for 30 minutes at 80 ℃, and filtering residues to obtain a finished liquid preparation.
Example 5:
a preparation method of a composition for treating gout and rheumatoid osteoarthritis comprises the following steps when the composition is a pill: selecting 30 g of astragalus root, 15 g of bighead atractylodes rhizome, 15 g of poria cocos, 8 g of chamomile, 2 g of honey-fried licorice root, 1 g of notopterygium root, 1 g of divaricate saposhnikovia root, 10g of schizophragma integrifolium, 10g of achyranthes root, 3 g of ligusticum wallichii, 2 g of radix bupleuri, 3 g of trogopterus dung, 3 g of myrrh, 6 g of semen brassicae, 0.06 g of fried fennel, 0.6 g of dried ginger, 2 g of cassia bark and 0.3 g of monkshood according to corresponding proportion, mixing, crushing, sieving by a 1000-mesh sieve, adding 167.94 g of water and 29.18 g of honey, and uniformly mixing to obtain the finished pill.
A preparation method of a composition for treating gout and rheumatoid osteoarthritis comprises the following steps when the composition is a liquid preparation: selecting 30 g of astragalus root, 15 g of bighead atractylodes rhizome, 15 g of poria cocos, 8 g of chamomile, 2 g of honey-fried licorice root, 1 g of notopterygium root, 1 g of divaricate saposhnikovia root, 10g of schizophragma integrifolium, 10g of achyranthes root, 3 g of ligusticum wallichii, 2 g of radix bupleuri, 3 g of trogopterus dung, 3 g of myrrh, 6 g of semen brassicae, 0.06 g of fried fennel, 0.6 g of dried ginger, 2 g of cassia bark and 0.3 g of monkshood according to corresponding proportion, mixing, soaking for 30 minutes, decocting for 30 minutes at 80 ℃, and filtering residues to obtain a finished liquid preparation.
The taking method comprises the following steps:
reducing uric acid: when the finished product is pills, 1 pill is taken as big honeyed pill, 2-3 pills are taken each day, and after the uric acid is normal, the curative effect is consolidated by continuously taking for 10-20 days without relapse.
Gout and rheumatoid diseases are taken 1-2 pills each time according to the weight of the disease, and 2-3 pills each day. After the medicine is taken until the symptoms disappear, the medicine is taken for about 20 days to consolidate the curative effect and no relapse occurs. According to the dosage, the tophus no matter how large or small, can be completely removed in about one week, so that the joint can be recovered as before.
Clinical cases:
patient 1: sex: female, age: 53 years old, Zhannan province, Lingbao county, Yi Zhong Dong che village.
Diagnosis of the condition: for years of rheumatoid diseases, the knee joints have deformation swelling and pain, and the knee joints are treated for many times in local hospitals, and the loxoprofen sodium dispersible tablets, the white paeony root total glycoside capsules, the leflunomide tablets, the diclofenac sodium suppositories and the like have no effect when being taken.
The treatment method comprises the following steps: the pills prepared in the example 5 are used for treating gout by 30 pills, and each pill is taken three times a day; one pill for each day and two pills for each day are used for consolidating the treatment of the eight ingredients with rehmannia pills of 40. The pain is not relieved after taking the medicine for 3 days, and after 6 days.
The treatment results are as follows: the joint swelling disappears, and the medicine is taken completely, so that the joint swelling is not relapsed.
Patient 2: sex: male, age: 50 years old, Wanggang in the bridge area of Xinyang city, Henan.
Diagnosis of the condition: the doctor visits 11 months and 2 days in 2018, and the uric acid is checked for 760 mu mol/L. Gout can be suffered for years, and waist is sour and easy to sweat. Gout is diagnosed.
The treatment method comprises the following steps: the pills prepared in the embodiment 5 are used for treating gout, and 30 pills are taken for one time, three times a day and ten days; the eight-ingredient rehmannia pill is 40 pills, is consolidated for operation, is taken one pill per day, is taken two times per day, and is taken for 20 days.
The treatment results are as follows: the gout does not relapse after the patient feeds back and the medicine is taken until the gout does not relapse.
Patient 3: sex: female, age: 62 years old, people staying in post-house city.
Diagnosis of the condition: uric acid was detected at 462. mu. mol/L at 6 months in 2021, which was slightly higher.
The treatment method comprises the following steps: pellets, 8 pellets, were prepared as in example 5 above. One pill is taken every day, and the pill is taken twice a day; one pill for each day and two pills for each day are 23 pills with 40 pills of eight ingredients and strengthening the recovery.
The treatment results are as follows: the patient fed back that the uric acid content (333 mu mol/L) is normal.
The present invention is not limited to the above alternative embodiments, and any other products in various forms can be obtained by the present invention, and the present invention is within the protection scope of the present invention. The above embodiments should not be construed as limiting the scope of the present invention, and it will be understood by those skilled in the art that modifications may be made to the technical solutions described in the above embodiments, or equivalent substitutions may be made to some or all of the technical features thereof, without departing from the scope of the present invention, and at the same time, such modifications or substitutions may not make the essence of the corresponding technical solutions depart from the scope of the embodiments of the present invention.
Claims (10)
1. The composition for treating gout and rheumatoid osteoarthritis is characterized by being prepared from the following raw materials in parts by mass:
10-40 parts of astragalus membranaceus, 5-20 parts of bighead atractylodes rhizome, 5-20 parts of poria cocos, 3-12 parts of chamomile, 0.5-4 parts of honey-fried licorice root, 0.5-2 parts of notopterygium root, 0.5-2 parts of divaricate saposhnikovia root, 5-15 parts of schizophragma integrifolium, 5-15 parts of achyranthes root, 0.3-6 parts of ligusticum wallichii, 0.5-4 parts of radix bupleuri, 0.3-6 parts of trogopterus dung, 0.3-6 parts of myrrh, 3-12 parts of semen brassicae, 0.03-0.1 part of fried fennel, 0.25-1 part of rhizoma zingiberis, 0.5-4 parts of cinnamon and 0.1-0.5 part of monkshood.
2. The composition for treating gout and rheumatoid osteoarthritis according to claim 1, wherein the composition is prepared from the following raw materials in parts by mass:
15-38 parts of astragalus membranaceus, 10-18 parts of bighead atractylodes rhizome, 10-18 parts of poria cocos, 5-10 parts of chamomile, 1-3 parts of honey-fried licorice root, 0.8-1.5 parts of notopterygium root, 0.8-1.5 parts of divaricate saposhnikovia root, 8-12 parts of schizophragma integrifolium, 8-12 parts of radix achyranthis bidentatae, 1-4 parts of ligusticum wallichii, 1-3 parts of radix bupleuri, 1-4 parts of trogopterus dung, 1-4 parts of myrrh, 5-8 parts of semen brassicae, 0.05-0.08 part of fried fennel, 0.5-0.8 part of dried ginger, 1-3 parts of cinnamon and 0.2-0.4 part of monkshood.
3. The composition for treating gout and rheumatoid osteoarthritis according to claim 2, wherein the composition is prepared from the following raw materials in parts by mass:
30 parts of astragalus membranaceus, 15 parts of bighead atractylodes rhizome, 15 parts of poria cocos, 8 parts of chamomile, 2 parts of honey-fried licorice root, 1 part of notopterygium root, 1 part of divaricate saposhnikovia root, 10 parts of schizophragma integrifolium, 10 parts of achyranthes root, 3 parts of ligusticum wallichii, 2 parts of radix bupleuri, 3 parts of trogopterus dung, 3 parts of myrrh, 6 parts of semen brassicae, 0.06 part of fried fennel, 0.6 part of dried ginger, 2 parts of cinnamon and 0.3 part of monkshood.
4. The composition for treating gout, rheumatoid osteoarthritis according to any of claims 1 to 3, wherein the composition is in the form of a pill or a liquid formulation.
5. A method for preparing a composition for the treatment of gout, rheumatoid osteoarthritis as claimed in any of claims 1 to 4, wherein the composition is in the form of a pill, comprising the steps of: selecting radix astragali, Atractylodis rhizoma, Poria, flos Chrysanthemi, radix Glycyrrhizae Preparata, Notopterygii rhizoma, radix Saposhnikoviae, cortex Schizophragmatis Integrifolii Radicis, Achyranthis radix, rhizoma Ligustici Chuanxiong, bupleuri radix, Oletum Trogopterori, Myrrha, semen Sinapis Albae, parched fructus Foeniculi, Zingiberis rhizoma, cortex Cinnamomi Japonici and radix Aconiti lateralis according to corresponding proportion, mixing, pulverizing, sieving, adding solvent, and mixing to obtain pill.
6. The method for preparing a composition for treating gout and rheumatoid osteoarthritis according to claim 5, wherein the selected herbs are radix astragali, rhizoma Atractylodis Macrocephalae, Poria, flos Chrysanthemi, radix Glycyrrhizae Preparata, rhizoma Et radix Notopterygii, radix Saposhnikoviae, cortex schizophragmatis integrifolii radicis, radix Achyranthis bidentatae, rhizoma Chuanxiong, radix bupleuri, Oletum Trogopterori, Myrrha, semen Sinapis, parched fructus Foeniculi, rhizoma Zingiberis, cortex cinnamomi japonici, and radix Aconiti lateralis Preparata, and the mixture is pulverized and sieved with a 800-mesh and 1000-mesh sieve.
7. The method for preparing a composition for treating gout and rheumatoid osteoarthritis according to claim 5, wherein the solvent is a mixture of water and honey;
the proportion of the water and the honey is 0.3-0.8 wt%: 0.2-0.7 wt%;
the weight ratio of the total mass of the mixed astragalus, bighead atractylodes rhizome, poria cocos, chamomile, honey-fried licorice root, notopterygium root, divaricate saposhnikovia root, schizophragma integrifolia, achyranthes root, szechuan lovage rhizome, Chinese thorowax root, trogopterus dung, myrrh, white mustard seed, fried fennel, dried ginger, cassia bark and monkshood to the solvent is 1: 0.5-0.8 wt%.
8. A method for preparing a composition for the treatment of gout and rheumatoid osteoarthritis according to any of claims 1 to 4, wherein the composition is a liquid preparation, comprising the steps of: selecting radix astragali, rhizoma Atractylodis Macrocephalae, Poria, flos Chrysanthemi, radix Glycyrrhizae Preparata, rhizoma Et radix Notopterygii, radix Saposhnikoviae, cortex schizophragmatis integrifolii radicis, radix Achyranthis bidentatae, rhizoma Chuanxiong, radix bupleuri, Oletum Trogopterori, Myrrha, semen Sinapis, parched fructus Foeniculi, rhizoma Zingiberis, cortex cinnamomi japonici, and radix Aconiti lateralis Preparata according to a certain proportion, mixing, soaking, decocting, and filtering to remove residues to obtain a liquid preparation.
9. The method for preparing a composition for treating gout and rheumatoid osteoarthritis according to claim 8, wherein the soaking is performed with water for 20-30 minutes.
10. The method for preparing a composition for treating gout and rheumatoid osteoarthritis according to claim 8, wherein the decoction temperature is 80-90 ℃; the decoction time is 30-55 minutes.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111194645.XA CN113679818A (en) | 2021-10-13 | 2021-10-13 | Composition for treating gout and rheumatoid osteoarthritis and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111194645.XA CN113679818A (en) | 2021-10-13 | 2021-10-13 | Composition for treating gout and rheumatoid osteoarthritis and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113679818A true CN113679818A (en) | 2021-11-23 |
Family
ID=78587635
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111194645.XA Pending CN113679818A (en) | 2021-10-13 | 2021-10-13 | Composition for treating gout and rheumatoid osteoarthritis and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113679818A (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1569053A (en) * | 2003-07-21 | 2005-01-26 | 天津达仁堂制药二厂 | Chinese medicinal herb composition for treating rheumatism |
CN101757322A (en) * | 2010-02-11 | 2010-06-30 | 香港晓源药业集团股份有限公司 | A kind of herbal medicine compound preparation for treating gouty arthritis and its preparation and application |
CN107596084A (en) * | 2017-09-07 | 2018-01-19 | 成都兴倍加生物科技有限责任公司 | A kind of endo-medicine for treating rheumatoid arthritis and preparation method thereof |
-
2021
- 2021-10-13 CN CN202111194645.XA patent/CN113679818A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1569053A (en) * | 2003-07-21 | 2005-01-26 | 天津达仁堂制药二厂 | Chinese medicinal herb composition for treating rheumatism |
CN101757322A (en) * | 2010-02-11 | 2010-06-30 | 香港晓源药业集团股份有限公司 | A kind of herbal medicine compound preparation for treating gouty arthritis and its preparation and application |
CN107596084A (en) * | 2017-09-07 | 2018-01-19 | 成都兴倍加生物科技有限责任公司 | A kind of endo-medicine for treating rheumatoid arthritis and preparation method thereof |
Non-Patent Citations (1)
Title |
---|
李有文等: "升阳益胃汤临床验案三则", 《安徽中医临床杂志》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102657835B (en) | Composition and medical liquor for treatment of high blood pressure/rheumatoid arthritis and preparation method and application of composition and medical liquor | |
CN104338043B (en) | A kind of medicine for improving immunity and preparation method thereof | |
CN101361911A (en) | External skin composition with wrinkle-dispelling function and production method thereof | |
CN108478767A (en) | Plaster for treating joint swelling and pain | |
CN105395842A (en) | Traditional Chinese medicine composition for treating diabetes and oral preparation and preparation method thereof | |
CN106039148B (en) | Liver-protecting Mongolian medicine | |
CN113679818A (en) | Composition for treating gout and rheumatoid osteoarthritis and preparation method thereof | |
CN103301337A (en) | Traditional Chinese medicine for treating bovine puerperal fever | |
CN103611099B (en) | A kind of Chinese medicine for the treatment of beriberi | |
CN107050154A (en) | It is a kind of to treat outer bath anaesthetic of gout and preparation method thereof | |
CN106983813B (en) | A pharmaceutical composition for treating lumbago and preparation method thereof | |
CN105561098A (en) | Medicine for treating erosive beriberi | |
CN104306784A (en) | Traditional Chinese medicine composition for treating rheumatoid arthritis as well as preparation method and application thereof | |
CN104083708A (en) | Traditional Chinese medicine ointment for treating scapulohumeral periarthritis | |
CN114712470B (en) | Medicine for treating deficiency of kidney of men and preparation method thereof | |
CN110237171B (en) | Medicine composition for femoral head necrosis and preparation method and application thereof | |
CN100571739C (en) | Herbal mixture of treatment cardiovascular disease and preparation method thereof | |
CN101401881B (en) | Chinese medicinal composition for treating poison produced by venomous insects | |
CN108042689B (en) | External traditional Chinese medicine preparation for treating herpes and preparation method thereof | |
CN101375962A (en) | Formulation for activating blood and freeing collateral vessels and preparation method thereof | |
CN113786454A (en) | Composition for eliminating body toxicity of bone meridian diseases and preparation method and application thereof | |
CN116585405A (en) | Traditional Chinese medicine composition for improving kidney function and strengthening kidney as well as preparation and application thereof | |
CN112451625A (en) | Traditional Chinese medicine watered pill for preventing and treating three highs and preparation method thereof | |
CN106266625B (en) | A Chinese medicinal composition for treating renal insufficiency, and its preparation method | |
CN113694112A (en) | Composition for treating cervical spondylosis and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20211123 |
|
RJ01 | Rejection of invention patent application after publication |